Other than expected, we found no significant relationship between measures of inflammatory burden (ESR and CRP), disease severity (DAS28 and HAQ), RA treatment patterns (use and dosage of steroids, use of synthetic DMARDs, and use of biological DMARDs), and microvascular reactivity (data not shown). The gene discussed is CRP; the disease is rheumatoid arthritis.